Know Cancer

or
forgot password

Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT)


N/A
18 Years
N/A
Not Enrolling
Male
Prostatic Cancer

Thank you

Trial Information

Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT)


Inclusion Criteria:



- Prostate cancer patient requiring androgen-ablation treatment: LHRH analogs, surgical
castration, antiandrogen treatment

- Provision of informed consent prior to conducting any study-related procedure

Exclusion Criteria:

- Patient involved in a Clinical Trial

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Metabolic syndrome

Outcome Time Frame:

3 months

Safety Issue:

No

Authority:

Spain: Ethics Committee

Study ID:

NIS-OES-DUM-2010/1

NCT ID:

NCT01284608

Start Date:

March 2011

Completion Date:

December 2012

Related Keywords:

  • Prostatic Cancer
  • Observational
  • prospective
  • metabolic changes
  • metabolic syndrome
  • diabetes
  • prostatic cancer
  • risk fracture
  • Prostatic Neoplasms

Name

Location